4.7 Article

Deep Learning Computer-aided Polyp Detection Reduces Adenoma Miss Rate: A United States Multi-center Randomized Tandem Colonoscopy Study (CADeT-CS Trial)

Journal

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY
Volume 20, Issue 7, Pages 1499-+

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.cgh.2021.09.009

Keywords

Adenoma Detection Rate; Adenoma Miss Rate; Computer-aided Detection; Deep Learning; Randomized Tandem Colonoscopy Study

Funding

  1. Shanghai Municipal Science and Technology Major Project [2021SHZDZX0102]
  2. Major Program of National Natural Science Foundation of China [12090024]
  3. Shanghai Natural Science Foundation [21ZR1431000]
  4. Wision LLC

Ask authors/readers for more resources

In a U.S. multicenter tandem colonoscopy randomized controlled trial, the use of a CADe-system was shown to decrease AMR and SSL miss rate while increasing first-pass APC compared to HDWL colonoscopy alone.
BACKGROUND & AIMS: Artificial intelligence-based computer-aided polyp detection (CADe) systems are intended to address the issue of missed polyps during colonoscopy. The effect of CADe during screening and surveillance colonoscopy has not previously been studied in a United States (U.S.) population. METHODS: We conducted a prospective, multi-center, single-blind randomized tandem colonoscopy study to evaluate a deep-learning based CADe system (EndoScreener, Shanghai Wision AI, China). Patients were enrolled across 4 U.S. academic medical centers from 2019 through 2020. Patients presenting for colorectal cancer screening or surveillance were randomized to CADe colonoscopy first or high-definition white light (HDWL) colonoscopy first, followed immediately by the other procedure in tandem fashion by the same endoscopist. The primary outcome was adenoma miss rate (AMR), and secondary outcomes included sessile serrated lesion (SSL) miss rate and adenomas per colonoscopy (APC). RESULTS: A total of 232 patients entered the study, with 116 patients randomized to undergo CADe colonoscopy first and 116 patients randomized to undergo HDWL colonoscopy first. After the exclusion of 9 patients, the study cohort included 223 patients. AMR was lower in the CADe-first group compared with the HDWL-first group (20.12% [34/169] vs 31.25% [45/144]; odds ratio [OR], 1.8048; 95% confidence interval [CI], 1.0780-3.0217; P=.0247). SSL miss rate was lower in the CADe-first group (7.14% [1/14]) vs the HDWL-first group (42.11% [8/19]; P=.0482). First-pass APC was higher in the CADe-first group (1.19 [standard deviation (SD), 2.03] vs 0.90 [SD, 1.55]; P=.0323). First-pass ADR was 50.44% in the CADe-first group and 43.64 % in the HDWL-first group (P=.3091). CONCLUSION: In this U.S. multicenter tandem colonoscopy randomized controlled trial, we demonstrate a decrease in AMR and SSL miss rate and an increase in first-pass APC with the use of a CADe-system when compared with HDWL colonoscopy alone.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Review Gastroenterology & Hepatology

Charting a path forward for clinical research in artificial intelligence and gastroenterology

Jeremy R. Glissen Brown, Akbar K. Waljee, Yuichi Mori, Prateek Sharma, Tyler M. Berzin

Summary: Gastroenterology has been at the forefront of integrating AI model development with clinical trial validation, with several initiatives underway to provide guidance on AI-specific study design and reporting. The rapid advancement of AI applications in clinical medicine highlights the need for clear guidance on trial design and reporting.

DIGESTIVE ENDOSCOPY (2022)

Editorial Material Gastroenterology & Hepatology

Therapeutics, Placebo, and the Importance of Hard Outcomes in Irritable Bowel Syndrome Research

Jeremy R. Glissen Brown, Anthony J. Lembo

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Review Gastroenterology & Hepatology

Steroid Use and Risk of Nonalcoholic Fatty Liver Disease in Patients With Inflammatory Bowel Disease Systematic Review and Meta-analysis

Hirsh D. Trivedi, Emily W. Lopes, Jeremy Glissen Brown, Shaan Dudani, Michelle Lai, Joseph D. Feuerstein, Theodore T. Pierce

Summary: This meta-analysis found no association between steroids and nonalcoholic fatty liver disease (NAFLD) among patients with inflammatory bowel disease (IBD). Therefore, steroids may not need to be withheld from patients with IBD for the purposes of preventing NAFLD.

JOURNAL OF CLINICAL GASTROENTEROLOGY (2023)

Review Oncology

Scoping out the future: The application of artificial intelligence to gastrointestinal endoscopy

Scott B. Minchenberg, Trent Walradt, Jeremy R. Glissen Brown

Summary: Artificial intelligence is rapidly growing in the field of gastrointestinal endoscopy. Research has focused on the identification and classification of gastrointestinal malignancies, particularly in polyp detection during screening colonoscopy. Despite promising results, the generalizability of most AI systems has not been evaluated.

WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2022)

Article Gastroenterology & Hepatology

Impact of Artificial Intelligence on Colonoscopy Surveillance After Polyp Removal: A Pooled Analysis of Randomized Trials

Yuichi Mori, Pu Wang, Magnus Loberg, Masashi Misawa, Alessandro Repici, Marco Spadaccini, Loredana Correale, Giulio Antonelli, Honggang Yu, Dexin Gong, Misaki Ishiyama, Shin-ei Kudo, Shunsuke Kamba, Kazuki Sumiyama, Yutaka Saito, Haruo Nishino, Peixi Liu, Jeremy R. Glissen Brown, Nabil M. Mansour, Seth A. Gross, Mette Kalager, Michael Bretthauer, Douglas K. Rex, Prateek Sharma, Tyler M. Berzin, Cesare Hassan

Summary: The use of AI during colonoscopy increases the proportion of patients needing intensive surveillance by approximately 35% in the United States and 20% in Europe. This contributes to improved cancer prevention but adds significant patient burden and healthcare costs.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2023)

Article Gastroenterology & Hepatology

Examining the Nocebo Effect in Trials of Neuromodulators for Use in Disorders of Gut-Brain Interaction

Jeremy R. Glissen Brown, Ava Sanayei, Samantha Proctor, Ryan Flanagan, Sarah Ballou, Paul A. Bain, Judy Nee

Summary: This study examined the adverse events (AE) and subject withdrawal in the treatment and placebo groups of randomized clinical trials (RCT) of neuromodulators for disorders of gut-brain interaction (DGBI). The findings showed that patients in the placebo groups also experienced AE and withdrawal, suggesting a strong nocebo effect. Nonspecific AE such as dizziness, headaches, and diarrhea occurred similarly in patients receiving placebo compared with those receiving neuromodulators.

AMERICAN JOURNAL OF GASTROENTEROLOGY (2023)

Review Gastroenterology & Hepatology

Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis

Muhammad Haseeb, Jeremy R. Glissen Brown, Umar Hayat, Camden Bay, Paul A. Bain, Pichamol Jirapinyo, Christopher C. Thompson

Summary: This study assessed the efficacy of transoral incisionless fundoplication (TIF) using the EsophyX device in treating atypical GERD symptoms. The results showed that TIF can effectively reduce these symptoms at 6 and 12 months of follow-up, with a high technical success rate and low adverse event rate. Most patients were satisfied with their health condition and a majority of them were able to stop using daily PPIs.

GASTROINTESTINAL ENDOSCOPY (2023)

Article Gastroenterology & Hepatology

Speedometer for withdrawal time monitoring during colonoscopy: a clinical implementation trial

Ishita Barua, Masashi Misawa, Jeremy R. Glissen Brown, Trent Walradt, Shin-ei Kudo, Sunil G. Sheth, Judy Nee, Johanna Iturrino, Rupa Mukherjee, Catherine P. Cheney, Mandeep S. Sawhney, Douglas K. Pleskow, Kensaku Mori, Magnus Loberg, Mette Kalager, Paulina Wieszczy, Michael Bretthauer, Tyler M. Berzin, Yuichi Mori

Summary: The study found that using speed monitoring during withdrawal did not increase withdrawal time or adenoma detection rate in colonoscopy.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2023)

Article Gastroenterology & Hepatology

Artificial intelligence empowers the second-observer strategy for colonoscopy: a randomized clinical trial

Pu Wang, Xiao-Gang Liu, Min Kang, Xue Peng, Mei-Ling Shu, Guan-Yu Zhou, Pei-Xi Liu, Fei Xiong, Ming-Ming Deng, Hong-Fen Xia, Jian-Jun Li, Xiao-Qi Long, Yan Song, Liang-Ping Li

Summary: In colonoscopy screening for colorectal cancer, human vision limitations may lead to higher miss rate of lesions. Artificial intelligence (AI) assistance has been demonstrated to improve polyp detection. This study aimed to compare the effectiveness of AI and human observer during colonoscopy.

GASTROENTEROLOGY REPORT (2023)

Article Gastroenterology & Hepatology

Initial experience of visualized biliary cannulation during ERCP

Wei-hui Liu, Xin-yu Huang, Xiao Hu, Pu Wang, Yun-chao Yang, Pei-xi Liu, Xiao-gang Liu

ENDOSCOPY (2023)

Meeting Abstract Gastroenterology & Hepatology

IMPACT OF ARTIFICIAL INTELLIGENCE ON COLONOSCOPY SURVEILLANCE AFTER POLYP REMOVAL: A POOLED ANALYSIS OF RANDOMIZED TRIALS

Yuichi Mori, Pu Wang, Magnus Loberg, Masashi Misawa, Alessandro Repici, Marco Spadaccini, Loredana Correale, Giulio Antonelli, Honggang Yu, Dexin Gong, Misaki Ishiyama, Shinei Kudo, Shunsuke Kamba, Kazuki Sumiyama, Yutaka Saito, Haruo Nishino, Peixi Liu, Jeremy R. Glissen Brown, Nabil M. Mansour, Seth Gross, Mette Kalager, Michael Bretthauer, Douglas K. Rex, Prateek Sharma, Tyler M. Berzin, Cesare Hassan

GASTROINTESTINAL ENDOSCOPY (2022)

No Data Available